Imricor Medical Valuation
| IMR Stock | 1.16 0.06 5.45% |
Today, the firm appears to be overvalued. Imricor Medical Systems retains a regular Real Value of USD0.95 per share. The prevalent price of the firm is USD1.16. Our model calculates the value of Imricor Medical Systems from evaluating the firm fundamentals such as Shares Outstanding of 270.18 M, return on equity of -2.75, and Return On Asset of -1.25 as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 3.9722 | Enterprise Value 328.6 M | Enterprise Value Ebitda (2.60) | Price Sales 380.1986 | Enterprise Value Revenue 277.7954 |
Overvalued
Today
Please note that Imricor Medical's price fluctuation is abnormally volatile at this time. Calculation of the real value of Imricor Medical Systems is based on 3 months time horizon. Increasing Imricor Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Imricor Medical's intrinsic value may or may not be the same as its current market price of 1.16, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.16 | Real 0.95 | Hype 1.11 |
The intrinsic value of Imricor Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Imricor Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Imricor Medical Systems helps investors to forecast how Imricor stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Imricor Medical more accurately as focusing exclusively on Imricor Medical's fundamentals will not take into account other important factors: Imricor Medical Cash |
|
Imricor Medical Total Value Analysis
Imricor Medical Systems is currently projected to have takeover price of 328.6 M with market capitalization of 313.4 M, debt of 10.42 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Imricor Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
328.6 M | 313.4 M | 10.42 M |
Imricor Medical Investor Information
About 20.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.17. Imricor Medical Systems had not issued any dividends in recent years. Based on the analysis of Imricor Medical's profitability, liquidity, and operating efficiency, Imricor Medical Systems is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Imricor Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Imricor Medical has an asset utilization ratio of 7.41 percent. This implies that the Company is making USD0.0741 for each dollar of assets. An increasing asset utilization means that Imricor Medical Systems is more efficient with each dollar of assets it utilizes for everyday operations.Imricor Medical Ownership Allocation
Imricor Medical Systems has a total of 270.18 Million outstanding shares. Imricor Medical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Imricor Medical Profitability Analysis
The company reported the revenue of 615.57 K. Net Loss for the year was (34.09 M) with loss before overhead, payroll, taxes, and interest of (1.53 M).About Imricor Medical Valuation
The stock valuation mechanism determines Imricor Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Imricor Medical Systems based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Imricor Medical. We calculate exposure to Imricor Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Imricor Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -2 M | -1.9 M |
Additional Tools for Imricor Stock Analysis
When running Imricor Medical's price analysis, check to measure Imricor Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imricor Medical is operating at the current time. Most of Imricor Medical's value examination focuses on studying past and present price action to predict the probability of Imricor Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imricor Medical's price. Additionally, you may evaluate how the addition of Imricor Medical to your portfolios can decrease your overall portfolio volatility.